Physician profile
Robert S Krombach
NPI 1952504276
$1,118.24
in general payments reported to CMS, 2019-2025
25 companies · $207 in 2025
The $207 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $507 · 2020: $86.03 · 2021: $11.55 · 2022: $21.40 · 2024: $286 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $492.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $177.40 | 2019-2021 | |
| Pfizer INC. | $155.55 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $86.17 | 2024-2025 | |
| Shield Therapeutics INC | $74.28 | 2024 | |
| Duchesnay USA Incorporated | $58.14 | 2019 | |
| Mayne Pharma Commercial LLC | $48.55 | 2025 | |
| Mission Pharmacal Company | $46.10 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $41.88 | 2019-2020 | |
| Allergan, INC. | $41.64 | 2019-2020 | |
| Hologic Sales and Service, LLC | $41.26 | 2019-2024 | Novasure |
| Roche Diagnostics Corporation | $39.08 | 2019 | |
| Exeltis, USA INC. | $35.16 | 2025 | Slynd |
| Astellas Pharma US INC | $34.90 | 2025 | Veozah |
| Organon LLC | $32.70 | 2024 | |
| Lupin INC. | $25.88 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $21.47 | 2019 | |
| Glaxosmithkline, LLC. | $21.34 | 2019 | |
| Biogen, INC. | $20.66 | 2024 | Vumerity |
| Mimedx Group, INC. | $20.41 | 2024 | |
| Smith+Nephew, INC. | $18.66 | 2024 | Pico 7 |
| Pacira Pharmaceuticals Incorporated | $18.59 | 2025 | Exparel |
| Avion Pharmaceuticals | $15.79 | 2019 | |
| Agile Therapeutics, INC. | $15.08 | 2024 | Twirla |
| Amag Pharmaceuticals, INC. | $13.86 | 2019 | |
| Mylan Pharmaceuticals INC. | $13.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Krombach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.